Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European Medicines Agency’s (EMA) CHMP for use in individuals aged six months and older.
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
In Depth
Mayo Clinic on MSN12hIn Depth
COVID-19 vaccines: Get the facts
Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
The winter season ushers in a new globally spreading COVID-19 variant called XEC, a mix of KS.1.1 and KP.3.3, both from the ...
Sunday's matchup in New Orleans could serve as a confidence-infusing springboard for the Eagles defense -- or, it could deepen doubts. Philadelphia Phillies (92-62, first in the NL East) vs. New ...
43 years ago today, Sandra Day O'Connor was sworn in as the first female Supreme Court Justice. She was approved in the Senate 99-0, ...